Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors. (Q53591737)
Jump to navigation
Jump to search
scientific article published in October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors. |
scientific article published in October 2006 |
Statements
Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors. (English)
1 reference
Robert Vessella
1 reference
Jennifer D Wu
1 reference
Kathy Haugk
1 reference
Ilsa Coleman
1 reference
Lillie Woodke
1 reference
Peter Nelson
1 reference
R Bruce Montgomery
1 reference
Dale L Ludwig
1 reference
Stephen R Plymate
1 reference
1 October 2006
1 reference
12
1 reference
6153-6160
1 reference
20 Pt 1
1 reference
Identifiers
1 reference